Topical advances in wound care (Q37269816)

19 August 2017

1 reference

title

Topical advances in wound care (English)

1 reference

19 August 2017

author name string

Alexander Stojadinovic

1

1 reference

19 August 2017

Jay W Carlson

2

1 reference

19 August 2017

Gregory S Schultz

3

1 reference

19 August 2017

Thomas A Davis

4

1 reference

19 August 2017

Eric A Elster

5

1 reference

19 August 2017

language of work or name

English

0 references

publication date

14 September 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

111

1 reference

19 August 2017

issue

2 Suppl

1 reference

19 August 2017

page(s)

S70-80

1 reference

General principles of wound healing

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

The basic science of wound healing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

EGF and TGF-alpha are potent chemoattractants for endothelial cells and EGF-like peptides are present at sites of tissue regeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Inflammatory mediators in wound healing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Growth factors and chronic wound healing: past, present, and future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Fibroblast biology in three-dimensional collagen matrices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Growth factors in wound healing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Interactions of cytokines, growth factors, and proteases in acute and chronic wounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Understanding chronic wounds: a unifying hypothesis on their pathogenesis and implications for therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Perioperative total parenteral nutrition in malnourished, gastrointestinal cancer patients: a randomized, clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Perioperative artificial nutrition in malnourished gastrointestinal cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Perioperative total parenteral nutrition in surgical patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Long-term glycemic control and postoperative infectious complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Identifying patients at high risk of surgical wound infection. A simple multivariate index of patient susceptibility and wound contamination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens: a randomized assessor-blinded multicenter trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Wound bed preparation: a systematic approach to wound management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Classifications for wound bed preparation and stimulation of chronic wounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Negative pressure wound therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Evidence-based medicine: vacuum-assisted closure in wound care management.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Efficacy and cost-effectiveness of a high-powered parallel waterjet for wound debridement.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Epidemiologic, clinical, and economic evaluation of an outbreak of clonal multidrug-resistant Acinetobacter baumannii infection in a surgical intensive care unit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Enzymatic versus autolytic debridement of chronic leg ulcers: a prospective randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

A review of the use of maggots in wound therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Maggot débridement therapy in outpatients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Maggot debridement therapy of infected ulcers: patient and wound factors influencing outcome - a study on 101 patients with 117 wounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Bioartificial dermal substitute: a preliminary report on its use for the management of complex combat-related soft tissue wounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Delayed wound closure based on bacterial counts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

The efficacy of systemic antibiotics in the treatment of granulating wounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Wound infection. A failure of wound healing caused by an imbalance of bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

A randomized trial of cadexomer iodine in decubitus ulcers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Cadexomer as well as cadexomer iodine induces the production of proinflammatory cytokines and vascular endothelial growth factor by human macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

A matched-pair, randomized study evaluating the efficacy and safety of Acticoat silver-coated dressing for the treatment of burn wounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Effect of a sustained silver-releasing dressing on ulcers with delayed healing: the CONTOP study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Acticoat versus Allevyn as a split-thickness skin graft donor-site dressing: a prospective comparative study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

A randomized comparative trial between Acticoat and SD-Ag in the treatment of residual burn wounds, including safety analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

The rate of re-epithelialization across meshed skin grafts is increased with exposure to silver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Pseudomonas infections in the thermally injured patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Less pain with Biatain-Ibu: initial findings from a randomised, controlled, double-blind clinical investigation on painful venous leg ulcers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Pain and quality of life for patients with venous leg ulcers: proof of concept of the efficacy of Biatain-Ibu, a new pain reducing wound dressing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

A pilot (real-life) randomised clinical evaluation of a pain-relieving foam dressing: (ibuprofen-foam versus local best practice).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Design of an artificial skin. II. Control of chemical composition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Parastomal hernia repair with acellular dermal matrix.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Immediate bilateral breast reconstruction with implants and inferolateral AlloDerm slings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Inferolateral AlloDerm hammock for implant coverage in breast reconstruction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Acellular cadaveric dermis (AlloDerm): a new alternative for abdominal hernia repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Pelvic, abdominal, and chest wall reconstruction with AlloDerm in patients at increased risk for mesh-related complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Reduction of adhesions with composite AlloDerm/polypropylene mesh implants for abdominal wall reconstruction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Utilization of human cadaveric acellular dermis for abdominal hernia reconstruction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Facial suspension with acellular human dermal allograft

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Use of regenerative human acellular tissue (AlloDerm) to reconstruct the abdominal wall following pedicle TRAM flap breast reconstruction surgery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Utility of acellular allograft dermis in the care of elderly burn patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

The use of acellular dermis in the prevention of Frey's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

The use of alloderm for the correction of nasal contour deformities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Acellular dermal matrix in the management of high-risk abdominal wall defects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Multilayer reconstruction of abdominal wall defects with acellular dermal allograft (AlloDerm) and component separation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Septal perforation repair with acellular human dermal allograft

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Use of human acellular dermal matrix in complex and contaminated abdominal wall reconstructions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Gamma-irradiated human skin allograft: a potential treatment modality for lower extremity ulcers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Ophthalmic plastic applications of acellular dermal allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Nonexpansive immediate breast reconstruction using human acellular tissue matrix graft (AlloDerm).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Early aggressive closure of the open abdomen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Acellular allodermis in burns surgery: 1-year results of a pilot trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Use of AlloDerm implant to prevent frey syndrome after parotidectomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Clinical evaluation of an acellular allograft dermal matrix in full-thickness burns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

A novel approach to the problem of intestinal fistulization arising in patients managed with open peritoneal cavities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

The effect of a tissue engineered bilayered living skin analog, over meshed split-thickness autografts on the healing of excised burn wounds. The Apligraf Burn Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Becaplermin gel in the treatment of pressure ulcers: a phase II randomized, double-blind, placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Clinical efficacy of becaplermin (rhPDGF-BB) gel. Becaplermin Gel Studies Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Use of topical recombinant human platelet-derived growth factor BB in abdominal wound separation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Role of platelet-derived growth factor as an adjunct to surgery in the management of pressure ulcers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

Randomized, multicenter, double-blind, and placebo-controlled trial using topical recombinant human acidic fibroblast growth factor for deep partial-thickness burns and skin graft donor site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.07.042

10.1016/J.YGYNO.2008.07.042

7 January 2021

Identifiers

DOI

1 reference

19 August 2017

1 reference